Results 291 to 300 of about 282,737 (397)

Spatial and temporal patterns of foot and mouth disease outbreaks (2011-2022) in cattle export-sourcing areas of southeastern Ethiopia. [PDF]

BMC Vet Res
Gizaw D, Beyene G, Ashenafi H, Legesse M, Kassa T.   +4 more
europepmc   +1 more source

Patient's Perspective on the Impact of Psoriasis on Their Quality of Life After 1 Year of Tildrakizumab Treatment: Despite Clinical Improvement, Persistence of a Potential Mental Cicatricial Memory of the Disease

JEADV Clinical Practice, EarlyView.
In this real‐life study, tildrakizumab confirmed its efficacy in treating moderate‐to‐severe psoriasis, including challenging areas. Despite good disease control, some patients expressed dissatisfaction, highlighting the cumulative mental burden of delayed effective treatment and underscoring the mental scars left by psoriasis, persisting even after ...
Ziad Reguiai, Pierre André Becherel, Jean Luc Perrot, Anne Claire Fougerousse, Edouard Begon, Claire Poreaux, Claire Boulard, Guillaume Chaby, Charlotte Fite, Inès Zaraa, Dominique Lons‐Danic, Anne‐Laure Liegeon, Josiane Parier, Nathalie Quiles‐Tsimaratos, Laure Mery‐Bossard, François Maccari, for the OMCCI Group   +16 more
wiley   +1 more source

Foot-and-Mouth Disease [PDF]

, 2001

core   +3 more sources

Spatiotemporal filtering modeling of hand, foot, and mouth disease: a case study from East China, 2009-2015. [PDF]

Epidemiol Infect
Chen X, Ba J, Liu Y, Huang J, Li K, Yin Y, Shi J, Xu J, Yuan R, Ward MP, Tu W, Yu L, Wang Q, Wang X, Chang Z, Zhang Z.   +15 more
europepmc   +1 more source

The Effect of Various Inactivating Agents on the Viral and Ribonucleic Acid Infectivities of Foot-and-Mouth Disease Virus and on its Attachment to Susceptible Cells

, 1963
F. Brown, B. Cartwright, D.L. Stewart
openalex   +1 more source

Hands, foot and mouth disease [PDF]

Clinical Medicine, 2005
openaire   +3 more sources

Treatment of Pyoderma Gangrenosum With Bimekizumab

JEADV Clinical Practice, EarlyView.
ABSTRACT Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis with no FDA‐approved treatments. Current therapies, including corticosteroids and immunomodulators, often show limited efficacy and nonspecific, conferring to higher risk of adverse events.
Kareena S. Garg, Adeel Ahmad, Leonardo Tjahjono   +2 more
wiley   +1 more source

The efficacy and effectiveness of enterovirus A71 vaccines against hand, foot, and mouth disease: A systematic review and meta-analysis. [PDF]

PLoS One
Yan X, Liu Y, Chen F, Chang Z, Zhang Z, Pons-Salort M, Grassly NC.   +6 more
europepmc   +1 more source

Atypical Gamma‐Delta‐Positive T‐Cell Lymphoproliferation With Clinical Features of Lymphomatoid Papulosis in Three Children

JEADV Clinical Practice, EarlyView.
ABSTRACT Primary cutaneous gamma‐delta T‐cell lymphoma has been described as an aggressive entity with a poor prognosis. However, gamma‐delta T‐cell receptor expression has been described in various types of skin lymphoproliferations. Paediatric cases of LyP are increasingly recognized, but paediatric LyP with a gamma‐delta phenotype have been rarely ...
Lachance Madeleine, Ram‐Wolff Caroline, Delisle Bernard, Sigg Nina, Bataille Pauline, Bourrat Emmanuelle, Dumont Maëlle, Battesti Gilles, Bozonnat Alizée, Louveau Baptiste, Mourah Samia, Moins‐Teisserenc Hélène, Bagot Martine, Lamant Laurence, Croue Anne, Michalak Sophie, BAH Ismael, Kempf Werner, Battistella Maxime, De Masson Adèle   +19 more
wiley   +1 more source

Heat shock protein 60 manipulates Foot-and-Mouth disease virus replication by regulating mitophagy. [PDF]

Cell Mol Life Sci
Tang J, Abdullah SW, Sun S, Guo H.
europepmc   +1 more source